These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2577695

  • 21. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.
    Miller JP, Faragher EB.
    Scand J Gastroenterol Suppl; 1989; 160():39-45. PubMed ID: 2573145
    [Abstract] [Full Text] [Related]

  • 22. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H.
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract] [Full Text] [Related]

  • 23. Helicobacter pylori, gastritis and duodenitis in the healing process of duodenal ulcer.
    Hsu CT, Yeh C, Cheng HH.
    J Formos Med Assoc; 1992 Jan; 91(1):81-4. PubMed ID: 1352340
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study].
    Bayerdörffer E, Kasper G, Pirlet T, Sommer A, Ottenjann R.
    Dtsch Med Wochenschr; 1987 Sep 11; 112(37):1407-11. PubMed ID: 3304929
    [Abstract] [Full Text] [Related]

  • 26. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F, Goff J, Scowcroft C, Jennings D, Greski-Rose P.
    Am J Gastroenterol; 1994 Aug 11; 89(8):1191-200. PubMed ID: 8053433
    [Abstract] [Full Text] [Related]

  • 27. [The role of Campylobacter pylori in the clinical course of chronic antral gastritis and duodenal ulcer].
    Kalinin AV, Spesivtsev VN, Sedletskiĭ VA, Belogolovtsev VA.
    Klin Med (Mosk); 1989 Oct 11; 67(10):64-6. PubMed ID: 2615309
    [No Abstract] [Full Text] [Related]

  • 28. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.
    Blaser MJ.
    J Infect Dis; 1990 Apr 11; 161(4):626-33. PubMed ID: 2181029
    [Abstract] [Full Text] [Related]

  • 29. [The role of Campylobacter pylori in gastroduodenal pathology].
    Sirigu F, Capeccioni S, Dessì A, Masia AM, Usai P.
    Recenti Prog Med; 1990 Mar 11; 81(3):142-5. PubMed ID: 2359867
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Campylobacter pylori--is there a connection with peptic ulcer?].
    Malfertheiner P, Bode G, Vanek E, Stanescu A, Lutz E, Blessing J, Ditschuneit H.
    Dtsch Med Wochenschr; 1987 Mar 27; 112(13):493-7. PubMed ID: 3829927
    [Abstract] [Full Text] [Related]

  • 32. Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis.
    Carrick J, Lee A, Hazell S, Ralston M, Daskalopoulos G.
    Gut; 1989 Jun 27; 30(6):790-7. PubMed ID: 2753403
    [Abstract] [Full Text] [Related]

  • 33. Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Relationship to gastritis and Campylobacter pylori infection.
    Spychal RT, Goggin PM, Marrero JM, Saverymuttu SH, Yu CW, Corbishley CM, Maxwell JD, Northfield TC.
    Gastroenterology; 1990 May 27; 98(5 Pt 1):1250-4. PubMed ID: 2323518
    [Abstract] [Full Text] [Related]

  • 34. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W.
    Z Gastroenterol; 1987 Sep 27; 25 Suppl 4():34-40. PubMed ID: 3687149
    [Abstract] [Full Text] [Related]

  • 35. Is antral gastrin important in the resistance of duodenal ulcers to H2 receptor antagonists or in recurrent ulceration after highly selective vagotomy?
    Primrose JN, Naik KS, Blackett RL, King RF, Holmfield JH, Lagopolous M, Johnston D.
    Gut; 1990 Jul 27; 31(7):763-6. PubMed ID: 1973394
    [Abstract] [Full Text] [Related]

  • 36. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
    Gisbert JP, Boixeda D, Alvarez Baleriola I, Redondo C, De Rafael L, Martín de Argila C, Hernández Ranz F.
    Rev Esp Enferm Dig; 1995 Apr 27; 87(4):281-7. PubMed ID: 7794634
    [Abstract] [Full Text] [Related]

  • 37. Helicobacter pylori and chronic active inflammation of the duodenum and stomach in duodenal ulcer patients treated with ranitidine, misoprostol, or an acid-neutralizing agent.
    Madsen JE, Vetvik K, AAse S.
    Scand J Gastroenterol; 1991 May 27; 26(5):465-70. PubMed ID: 1908115
    [Abstract] [Full Text] [Related]

  • 38. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E, Ottenjann R.
    Scand J Gastroenterol Suppl; 1988 May 27; 142():93-100. PubMed ID: 3047854
    [Abstract] [Full Text] [Related]

  • 39. [Campylobacter pylori in patients with gastroduodenal disease].
    Fukuda Y, Yamamoto I, Inoue H, Mikami J, Tamura K, Satomi M, Shimoyama T.
    Gan To Kagaku Ryoho; 1990 Apr 27; 17(4 Pt 1):575-88. PubMed ID: 2321983
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.